With another ongoing spike in the number of coronavirus cases and hospitalizations across the U.S., IMF Chairman of the Board Brian G.M. Durie reassesses the situation in his blog to clarify what actions need to be taken and to provide proper guidance to myeloma patients anew. Dr. Durie brings to light the rise of new omicron subvariants, the possibility of a “sixth wave,” and elaborates on ways to keep safe during these new COVID-19 surges and waves. He advises myeloma patients to reach out to the IMF’s InfoLine for expert advice and support during these difficult times. Call the InfoLine at 1-800-452-2873 and leave a message (phone lines are open Monday through Friday 9 a.m. to 4 p.m. PST) or email [email protected].

published May 5, 2022

A second COVID-19 booster of the Pfizer or Moderna Vaccine for adults aged 50 or older and for the immunocompromised aged 18 and above was recently authorized by the FDA and is highly recommended by the CDC. In his blog, IMF Chairman of the Board Dr. Brian G.M. Durie discusses compelling reasons for getting a second COVID-19 booster shot for myeloma patients — antibody levels can go back to prior levels after a decline from the first COVID-19 booster; the scarcity of Evusheld™; and the possibility of an omicron BA.2 variant surge. Dr. Durie also advises myeloma patients to continue masking to avoid a COVID-19 infection, and to keep staying safe and resilient in this changed, post-COVID world. 

published March 31, 2022

As the omicron surge winds down and we are in a much better position, IMF Chairman of the Board Dr. Brian G.M. Durie talks about how we must keep exercising caution to shield ourselves from the emergence of new Variants of Concern (VOC). With tracking metrics in place and communities having strong response plans, Dr. Durie believes that we are on the right track when it comes to protecting ourselves against infection and instituting early treatment. Citing Los Angeles County as an example, Dr. Durie elaborates on metrics and response strategies that have been put in place by the county for poor and vulnerable communities and how they impact myeloma patients. He strongly advises utilizing these valuable metrics and tools to ensure our continuing safety from COVID-19. 

published March 17, 2022

With COVID-19 mandates easing up, the world is learning to live with COVID-19 and the new normal. Dr. Durie emphasizes the importance of continued self-protection and managing the needs and expectations of myeloma patients. He also discusses the partial but promising outcome of a COVID-19-related survey among myeloma patients and caregivers; important shifts made by the IMF in terms of virtual learning and vital information dissemination to myeloma patients; changes in therapy, access to vaccines and therapies, and day-to-day care. With all the challenges we face on a day-to-day, Dr. Durie advises to see “beauty among the struggles” and compares life to a tide pool where, amidst “the enchanting display of natural beauty,” it is also “an arena for endless struggles.”   

published February 24, 2022